Trends in tramadol: pharmacology, metabolism, and misuse

K Miotto, AK Cho, MA Khalil, K Blanco… - Anesthesia & …, 2017 - journals.lww.com
Tramadol is a unique analgesic medication, available in variety of formulations, with both
monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly …

Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

J Bowes, AJ Brown, J Hamon, W Jarolimek… - Nature reviews Drug …, 2012 - nature.com
In vitro pharmacological profiling is increasingly being used earlier in the drug discovery
process to identify undesirable off-target activity profiles that could hinder or halt the …

The serotonin syndrome: from molecular mechanisms to clinical practice

J Francescangeli, K Karamchandani, M Powell… - International journal of …, 2019 - mdpi.com
The serotonin syndrome is a medication-induced condition resulting from serotonergic
hyperactivity, usually involving antidepressant medications. As the number of patients …

Cardiac effects of opioid therapy

A Chen, MA Ashburn - Pain Medicine, 2015 - academic.oup.com
Objective The use of opioids to treat chronic pain has come under increased scrutiny, as
such use has been associated with significant risk of death, with limited data regarding the …

Psychedelic 5-methoxy-N, N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions

HW Shen, XL Jiang, J C. Winter… - Current drug metabolism, 2010 - benthamdirect.com
5-Methoxy-N, N-dimethyltryptamine (5-MeO-DMT) belongs to a group of naturally-occurring
psychoactive indolealkylamine drugs. It acts as a nonselective serotonin (5-HT) agonist and …

CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity

PK Gillman - Journal of psychopharmacology, 2011 - journals.sagepub.com
Methylene blue has only recently been noted to cause severe central nervous system
toxicity. Methylene blue is used for various conditions, including, intravenously, in …

Conundrums in neurology: diagnosing serotonin syndrome–a meta-analysis of cases

U Werneke, F Jamshidi, DM Taylor, M Ott - BMC neurology, 2016 - Springer
Background Serotonin syndrome is a toxic state, caused by serotonin (5HT) excess in the
central nervous system. Serotonin syndrome's main feature is neuro-muscular …

New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review

F Schifano, S Chiappini, A Miuli, JM Corkery… - Experimental …, 2021 - Elsevier
The use of several new psychoactive substances (NPS) has become very popular and is
posing global health risks. Chemically and pharmacologically diverse molecules are …

A review of SSRIs and SNRIs in neuropathic pain

YC Lee, PP Chen - Expert opinion on pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Selective serotonin reuptake inhibitors (SSRIs) and serotonin
noradrenaline reuptake inhibitors (SNRIs) are becoming increasingly used in the treatment …

[HTML][HTML] Animal models of the serotonin syndrome: a systematic review

R Haberzettl, B Bert, H Fink, MA Fox - Behavioural brain research, 2013 - Elsevier
The serotonin syndrome (SS) is a potentially life-threatening disorder in humans which is
induced by ingestion of an overdose or by combination of two or more serotonin (5-HT) …